Call for abstracts for the International Society for the Study of Drug Policy (ISSDP)13th annual conference

Call for abstracts for the International Society for the Study of Drug Policy (ISSDP)13th annual conference

The International Society for the Study of Drug Policy (ISSDP) is a society of scholars committed to advancing drug policy research. The 13th ISSDP conference will be held in Paris, France on 22-24 May 2019.

The Conference is a unique occasion to present your latest findings to an intellectually engaged, diverse and dedicated scholarly community, and to immerse yourself in the state of the art research across the full spectrum of drug policy research, with the participation of leading international scholars.
Researchers and/or practitioners interested in contributing scholarly papers that advance future thinking regarding the development, assessment, or evolution of drug policy locally, nationally or internationally are encouraged to submit abstracts.

Dates to remember

Submissions open: December 15th, 2018
Submissions close: February 10th, 2019
Decision of Scientific Committee March 4th, 2019
Complete Written papers (2500 to 4000 words) for selected abstracts deadline April 22nd 2019

Submission process: papers, panels, workshops

Participants may present only one paper, although they may be a contributing author on more than one.
All submissions are peer reviewed, and decisions will be provided by the beginning of March 2019:

Paper presentation (15 min):

– To be submitted through the website => SUBMIT YOUR ABSTRACT
– Provide 1 structured abstract of 2 500 signs maximum (roughly 350 words)
– Papers provide an opportunity to present original research findings related to any of the conference themes or other drug policy topics.
– The presentation slots are 15 minutes,
– A written version of your paper will need to be provided to in advance of the conference. Expectation is that participants will have read the paper and hence the oral presentation focuses on key findings and then opportunity for discussion.

Panel session (3-4 speakers on the same topic, 1.5 hours)

– To be submitted through the website => SUBMIT YOUR ABSTRACT
– Provide 3-4 abstracts (1 per speaker) around a central theme, with a chairperson nominated by you, who will coordinate and oversee the panel, including the discussion components of the panel session.
– In all your submission, please use structured abstract headings (e.g. introduction, methods, results, discussion) for your 200-400 words abstract. If accepted, your abstract will appear as you have submitted it, in the book of abstracts.

Workshop Session (Interactive Session 1,5 hours)

– Interactive session, please send your proposal at
– These are highly interactive, drug policy research skills-focused sessions, open to all registered participants, with numbers capped at the workshop convenor’s request.
– Workshops will be interactive and skills-based, and are 1.5 hours in length. They do not involve didactic presentations.
– Please provide a description of the aims of the workshop, along with an outline of the interactive, skills sharing training that will occur in the workshop.

All submissions (papers, panels and workshops) are peer reviewed by the Scientific Committee and its members’ scores are used to then select the successful submissions. Those selected to present are required to register for the conference. Participants may present only one paper/panel/Workshop, although they may be a contributing author on more than one.


International Journal of Drug Policy (IJDP) Special Themed edition

ISSDP is working in partnership with the IJDP, the official journal partner to the 13rd annual conference. Selected papers presented at the ISSDP conference will be considered for publication as part of guest-edited themed sections in the IJDP.


We invite abstracts on all aspects of drug policy, but particularly on the conference themes. The conference themes this year include:
– Theories in drug policy
– Harm reduction epistemologies
– Comparative policy analyses
– Methodological innovation in drug policy analysis
– Regulatory options and policy alternatives for currently illicit drugs
– Diversity in drug policy: accommodating ethnicity, class, gender and culture
– Globalization and relationships between South and North. Drugs and development
– Interrelationships between drug policy and social policy
– Synergies and conflicts between drug policy at the local, national and international level
– The role of different kinds of stakeholders and their position in drug policy
– Peer engagement/user involvement in drug policy
– Drug supply and suppliers, internet markets for drugs
– Opioid use and responses – Opioid crisis
– Cannabis regulation models
– New Psychoactive Drugs